DG SANTE Publishes Report on Blood Health Safety

On August 26, the Directorate-General for Health and Food Safety of the European Commission (DG SANTE) published its Summary of the 2024 annual reporting of serious adverse reactions and events for blood and blood components. The report is an analysis of the Serious Adverse Reactions and Events data from 30 European countries for the year 2023.

  • The report records a steady increase in transfusion safety across Europe, with stable or declining rates of serious adverse reactions and events over the past seven years.
  • While human error remains the primary cause of adverse events, it’s steadily dropping, while equipment failures are on the rise.
  • The study concluded that greater standardization in reporting and data gathering is important, that human error should be reduced through training, procedural verification and digital tracking systems, and that better post donation support would improve donor experience and reduce vasovagal reactions.

 

Please find the report here.

Stay up to date

    © CSL 2026

    Blood & Beyond is a multi-stakeholder initiative funded by CSL, involving experts from the fields of haematology, transfusion medicine, anaesthesiology, patient blood management, nursing, patient advocacy, health economics, and hospital management, with support from policymakers committed to driving improvements in this area. The aim of the initiative is to raise awareness of the importance of good blood health and of the impact of anaemia on patients, healthcare systems and society at large, with the overarching goal to help advance policies and practices that improve patient outcomes by supporting patient-centricity in anaemia prevention, diagnosis, and management through patient blood management (PBM) and innovation.

    Contact

    For further information and queries, please contact the Blood and Beyond Secretariat: javier.lopezpanos@dgagroup.com

    Privacy Preference Center